Login

Danielle S. Poirier

ORCID: 0000-0002-8139-5539
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
A5045748261
Research Areas
  • Immunotherapy and Immune Responses
  • Advancements in Transdermal Drug Delivery
  • Influenza Virus Research Studies
  • Immune Response and Inflammation
  • Toxin Mechanisms and Immunotoxins
  • Dermatology and Skin Diseases

GlaxoSmithKline (Canada)
 2015

 Hepatitis B surface antigen incorporated in dissolvable microneedle array patch is antigenic and thermostable
OPENALEX - Publications 
Danielle S. Poirier Frédéric Renaud Vincent Dewar Laurent Strodiot Florence Wauters and 9 more Jim Janimak Toshio Shimada Tatsuya Nomura K Kabata Koji Kuruma Takayuki Kusano Masaki Sakai Hideo Nagasaki Takayoshi Oyamada

Alternatives to syringe-based administration are considered for vaccines. Intradermal vaccination with dissolvable microneedle arrays (MNA) appears promising in this respect, as an easy-to-use and painless method. In work, we have developed MNA patch (MNAP) made of hydroxyethyl starch (HES) chondroitin sulphate (CS). swines, hepatitis B surface antigen (HBsAg) formulated the saponin QS-21 adjuvant, both incorporated HES-based MNAP, demonstrated same level immunogenicity a commercially...

10.1016/j.biomaterials.2017.08.038 article EN cc-by Biomaterials 2017-08-29
 Methylglycol chitosan and a synthetic TLR4 agonist enhance immune responses to influenza vaccine administered sublingually
OPENALEX - Publications 
Justin L. Spinner Hardeep S. Oberoi Yvonne M. Yorgensen Danielle S. Poirier David J. Burkhart and 2 more Martin Plante Jay T. Evans

10.1016/j.vaccine.2015.08.086 article EN Vaccine 2015-09-21
Coming Soon ...